XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Parent Company Only Condensed Financial Information
12 Months Ended
Dec. 31, 2022
Condensed Financial Information Disclosure [Abstract]  
Parent Company Only Condensed Financial Information
23.
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION

Condensed balance sheets (in thousands)

 

 

 

As of December 31,

 

 

 

2021

 

 

2022

 

 

2022

 

 

 

RMB

 

 

RMB

 

 

US$

 

ASSETS

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

24,500

 

 

 

36,526

 

 

 

5,296

 

Short-term investments

 

 

700,052

 

 

 

20,894

 

 

 

3,029

 

Amounts due from subsidiaries

 

 

8,496

 

 

267,947

 

 

 

38,848

 

Other current assets

 

 

1,723

 

 

 

854

 

 

 

124

 

Total current assets

 

 

734,771

 

 

 

326,221

 

 

 

47,297

 

TOTAL ASSETS

 

 

734,771

 

 

 

326,221

 

 

 

47,297

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

Accrued expenses and other current liabilities

 

 

4,133

 

 

 

16,044

 

 

 

2,326

 

Amounts due to subsidiaries

 

 

2,569

 

 

 

 

 

 

 

Total current liabilities

 

 

6,702

 

 

 

16,044

 

 

 

2,326

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

 

6,702

 

 

 

16,044

 

 

 

2,326

 

Shareholders’ equity

 

 

 

 

 

 

 

 

 

Class A ordinary shares (US$0.000002 par value per share;
   
20,000,000,000 and 20,000,000,000 shares authorized as
   of December 31, 2021 and 2022, respectively;
299,797,728
   and
299,797,728 shares issued as of December 31, 2021 and
   2022,
270,054,584 and 269,942,489 shares outstanding as of
   December 31, 2021 and 2022, respectively)

 

 

3

 

 

 

3

 

 

 

1

 

Class B ordinary shares (US$0.000002 par value per share;
   
2,500,000,000 and 2,500,000,000 shares authorized as of
   December 31, 2021 and 2022, respectively;
54,543,800 and
   
54,543,800 shares issued and outstanding as of December 31,
   2021 and 2022, respectively)

 

 

1

 

 

 

1

 

 

 

 

Additional paid-in capital

 

 

13,685,062

 

 

 

13,922,811

 

 

 

2,018,618

 

Treasury stock

 

 

(7,042

)

 

 

(20,666

)

 

 

(2,997

)

Accumulated deficit

 

 

(12,765,713

)

 

 

(13,580,086

)

 

 

(1,968,928

)

Accumulated other comprehensive loss

 

 

(184,242

)

 

 

(11,886

)

 

 

(1,723

)

TOTAL SHAREHOLDERS’ EQUITY

 

 

728,069

 

 

 

310,177

 

 

 

44,971

 

TOTAL LIABILITIES AND SHAREHOLDER’S EQUITY

 

 

734,771

 

 

 

326,221

 

 

 

47,297

 

 

23.
PARENT COMPANY ONLY CONDENSED FINANCIAL INFORMATION (CONTINUED)

Condensed statements of comprehensive loss (in thousands)

 

 

 

For the years ended December 31,

 

 

 

2020

 

 

2021

 

 

2022

 

 

2022

 

 

 

RMB

 

 

RMB

 

 

RMB

 

 

US$

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

 

(142,186

)

 

 

(271,436

)

 

 

(578,473

)

 

 

(83,871

)

Total operating expenses

 

 

(142,186

)

 

 

(271,436

)

 

 

(578,473

)

 

 

(83,871

)

Loss from operations

 

 

(142,186

)

 

 

(271,436

)

 

 

(578,473

)

 

 

(83,871

)

Interest income

 

 

7,699

 

 

 

8,611

 

 

 

1,670

 

 

 

242

 

Interest expenses

 

 

(21,334

)

 

 

 

 

 

 

 

 

 

Other expenses

 

 

(29,141

)

 

 

 

 

 

 

 

 

 

Changes in fair value of warrant liabilities

 

 

11,450

 

 

 

(44,457

)

 

 

 

 

 

 

Share of losses in subsidiaries

 

 

(3,003,402

)

 

 

(6,121,777

)

 

 

(237,570

)

 

 

(34,444

)

Net loss.

 

 

(3,176,914

)

 

 

(6,429,059

)

 

 

(814,373

)

 

 

(118,073

)

Accretions of redeemable convertible preferred shares

 

 

(320,301

)

 

 

(288,380

)

 

 

 

 

 

 

Net loss attributable to ordinary shareholders

 

 

(3,497,215

)

 

 

(6,717,439

)

 

 

(814,373

)

 

 

(118,073

)

Other comprehensive (loss)/income, net of tax of nil:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

(53,370

)

 

 

(161,281

)

 

 

172,356

 

 

 

24,989

 

Comprehensive loss.

 

 

(3,230,284

)

 

 

(6,590,340

)

 

 

(642,017

)

 

 

(93,084

)

Accretions of redeemable convertible preferred shares

 

 

(320,301

)

 

 

(288,380

)

 

 

 

 

 

 

Comprehensive loss attributable to ordinary shareholders.

 

 

(3,550,585

)

 

 

(6,878,720

)

 

 

(642,017

)

 

 

(93,084

)

 

Condensed statements of cash flows (in thousands)

 

 

 

For the year ended December 31,

 

 

 

2020

 

 

2021

 

 

2022

 

 

2022

 

 

 

RMB

 

 

RMB

 

 

RMB

 

 

US$

 

Net cash generated from/(used in) operating activities

 

 

7,564

 

 

 

(4,066

)

 

 

(29,541

)

 

 

(4,284

)

Net cash (used in)/generated from investing activities

 

 

(1,957,689

)

 

 

(7,713,202

)

 

 

43,166

 

 

 

6,259

 

Net cash generated from/(used in) financing activities

 

 

2,281,673

 

 

 

7,215,688

 

 

 

(16,674

)

 

 

(2,417

)

Effect of exchange rate changes on cash and
   cash equivalents and restricted cash

 

 

(41,844

)

 

 

(25,625

)

 

 

15,075

 

 

 

2,186

 

Net increase/(decrease) in cash and cash equivalents

 

 

289,704

 

 

 

(527,205

)

 

 

12,026

 

 

 

1,744

 

Cash and cash equivalents at beginning of the year

 

 

262,001

 

 

 

551,705

 

 

 

24,500

 

 

 

3,552

 

Cash and cash equivalents at end of the year.

 

 

551,705

 

 

 

24,500

 

 

 

36,526

 

 

 

5,296

 

 

(a)
Basis of presentation

Condensed financial information is used for the presentation of the Company, or the parent company. The condensed financial information of the parent company has been prepared using the same accounting policies as set out in the Company’s consolidated financial statements except that the parent company used the equity method to account for investment in its subsidiaries.

The Company records its investment in its subsidiaries under the equity method of accounting as prescribed in ASC 323-10 Investment-Equity Method and Joint Ventures, such investment is presented on the condensed balance sheets as “Investment in subsidiaries” and share of the subsidiaries’ losses as “Share of losses in subsidiaries” on the condensed statements of comprehensive loss. Under the equity method of accounting, the Company’s carrying amount of its investment in subsidiaries for its share of the subsidiaries cumulative losses were reduced to nil and the carrying amount of “Amounts due from subsidiaries” was further adjusted as of December 31, 2021 and 2022.

The subsidiaries did not pay any dividends to the Company for the periods presented.

The Company does not have significant commitments or long-term obligations as of December 31, 2021 and 2022.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted and as such, these Company-only financial statements should be read in conjunction with the Group’s consolidated financial statements.